Precision-wellness sites all look the same: a soft gradient, a smiling person, a promise about your potential. Nexus Health couldn't afford that. Their buyer is a practitioner deciding whether to put a patient's DNA through someone else's engine.

The harder problem was structural. Nexus has two things — BioMatrix™, the AI that reads DNA and blood data, and BaselineONE, the portal where clinicians act on it. Explained separately, they sound redundant. Explained together, they sound vague.

So the page does both, in order. First a split panel that gives each its own definition — the brain behind the platform, and where clinicians take control. Then a five-step flow that dissolves the split: intake, analysis, scoring, protocol, clinician review. By the time you reach the capability list, the two names have stopped competing and started describing a pipeline.

The visual system does the same work. Clinical navy for anything that makes a claim, mint and dimensional glass for the top of the funnel. Real dashboard states instead of decorative ones, because a screenshot that shows scored data is an argument that the data gets scored.

A brand for a clinical product has to earn permission before it asks for a demo.